Abvc Biopharma Stock Price History
| ABVC Stock | USD 3.35 0.23 6.42% |
Below is the normalized historical share price chart for ABVC Biopharma extending back to November 10, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ABVC Biopharma stands at 3.35, as last reported on the 19th of July, with the highest price reaching 3.60 and the lowest price hitting 3.35 during the day.
If you're considering investing in ABVC Stock, it is important to understand the factors that can impact its price. ABVC Biopharma is extremely dangerous given 3 months investment horizon. ABVC Biopharma secures Sharpe Ratio (or Efficiency) of 0.26, which signifies that the company had a 0.26 % return per unit of volatility over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.74% are justified by taking the suggested risk. Use ABVC Biopharma Coefficient Of Variation of 416.29, mean deviation of 7.41, and Market Risk Adjusted Performance of 1.82 to evaluate company specific risk that cannot be diversified away. At present, ABVC Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. . As of July 19, 2025, Price To Sales Ratio is expected to decline to 13.67. In addition to that, Price Earnings Ratio is expected to decline to -1.57. ABVC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2017 | 200 Day MA 0.9637 | 50 Day MA 1.9457 | Beta 0.186 |
Sharpe Ratio = 0.2592
| Best Portfolio | Best Equity | |||
| Good Returns | ABVC | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.56 actual daily | 94 94% of assets are less volatile |
Expected Return
| 2.74 actual daily | 55 55% of assets have lower returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average ABVC Biopharma is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABVC Biopharma by adding it to a well-diversified portfolio.
Price Book 11.2176 | Enterprise Value Ebitda (1.90) | Price Sales 111.9004 | Shares Float 11.4 M | Wall Street Target Price 2.02 |
ABVC Biopharma Stock Price History Chart
There are several ways to analyze ABVC Stock price data. The simplest method is using a basic ABVC candlestick price chart, which shows ABVC Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 8, 2025 | 4.74 |
| Lowest Price | April 22, 2025 | 0.83 |
ABVC Biopharma July 19, 2025 Stock Price Synopsis
Various analyses of ABVC Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ABVC Stock. It can be used to describe the percentage change in the price of ABVC Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ABVC Stock.| ABVC Biopharma Price Daily Balance Of Power | (0.92) | |
| ABVC Biopharma Price Rate Of Daily Change | 0.94 | |
| ABVC Biopharma Accumulation Distribution | 10,457 | |
| ABVC Biopharma Price Action Indicator | (0.24) |
ABVC Biopharma July 19, 2025 Stock Price Analysis
ABVC Stock Price History Data
The price series of ABVC Biopharma for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 3.91 with a coefficient of variation of 53.27. The prices are distributed with arithmetic mean of 1.86. The median price for the last 90 days is 1.54. The company had 1:10 stock split on 25th of July 2023. ABVC Biopharma issued dividends on 2019-05-08.| Open | High | Low | Close | Volume | ||
| 07/18/2025 | 3.59 | 3.60 | 3.35 | 3.35 | 150,574 | |
07/17/2025 | 3.52 | 3.61 | 3.30 | 3.58 | 408,411 | |
07/16/2025 | 3.55 | 3.92 | 3.48 | 3.52 | 402,789 | |
07/15/2025 | 3.55 | 3.72 | 3.28 | 3.57 | 398,133 | |
07/14/2025 | 4.02 | 4.05 | 3.38 | 3.51 | 719,996 | |
07/11/2025 | 3.50 | 4.17 | 3.46 | 3.97 | 1,193,794 | |
07/10/2025 | 4.60 | 4.95 | 3.28 | 3.35 | 1,427,792 | |
07/09/2025 | 4.75 | 4.78 | 4.11 | 4.68 | 795,205 | |
07/08/2025 | 4.10 | 5.48 | 4.07 | 4.74 | 2,225,804 | |
07/07/2025 | 3.11 | 4.00 | 3.04 | 3.99 | 1,191,631 | |
07/03/2025 | 3.08 | 3.12 | 2.80 | 3.11 | 662,074 | |
07/02/2025 | 2.44 | 3.10 | 2.38 | 3.10 | 1,168,111 | |
07/01/2025 | 2.27 | 2.45 | 2.27 | 2.42 | 493,979 | |
06/30/2025 | 2.65 | 2.70 | 2.16 | 2.23 | 955,045 | |
| 06/27/2025 | 2.23 | 2.60 | 2.20 | 2.59 | 809,240 | |
06/26/2025 | 2.15 | 2.25 | 2.14 | 2.19 | 292,490 | |
06/25/2025 | 2.12 | 2.29 | 2.12 | 2.12 | 372,520 | |
| 06/24/2025 | 1.98 | 2.07 | 1.96 | 2.06 | 191,151 | |
06/23/2025 | 1.85 | 2.04 | 1.85 | 1.96 | 199,086 | |
06/20/2025 | 1.94 | 1.97 | 1.84 | 1.84 | 242,822 | |
06/18/2025 | 2.05 | 2.06 | 1.89 | 1.94 | 223,485 | |
06/17/2025 | 1.92 | 2.25 | 1.92 | 2.00 | 646,117 | |
06/16/2025 | 1.82 | 1.98 | 1.78 | 1.95 | 481,959 | |
06/13/2025 | 1.80 | 1.85 | 1.74 | 1.77 | 284,842 | |
06/12/2025 | 1.67 | 1.85 | 1.58 | 1.85 | 362,541 | |
06/11/2025 | 1.64 | 1.70 | 1.60 | 1.67 | 83,406 | |
06/10/2025 | 1.64 | 1.68 | 1.60 | 1.66 | 229,847 | |
06/09/2025 | 1.59 | 1.65 | 1.55 | 1.62 | 298,634 | |
06/06/2025 | 1.55 | 1.65 | 1.48 | 1.54 | 374,542 | |
06/05/2025 | 1.57 | 1.61 | 1.42 | 1.50 | 349,242 | |
06/04/2025 | 1.69 | 1.73 | 1.55 | 1.58 | 310,586 | |
| 06/03/2025 | 1.62 | 1.81 | 1.62 | 1.65 | 527,753 | |
06/02/2025 | 1.38 | 1.61 | 1.38 | 1.54 | 591,711 | |
05/30/2025 | 1.39 | 1.40 | 1.33 | 1.37 | 129,240 | |
| 05/29/2025 | 1.38 | 1.43 | 1.34 | 1.40 | 119,945 | |
05/28/2025 | 1.39 | 1.41 | 1.30 | 1.37 | 211,877 | |
05/27/2025 | 1.19 | 1.39 | 1.19 | 1.38 | 419,590 | |
05/23/2025 | 1.20 | 1.21 | 1.11 | 1.15 | 169,464 | |
| 05/22/2025 | 1.18 | 1.23 | 1.14 | 1.21 | 250,432 | |
05/21/2025 | 1.32 | 1.36 | 1.15 | 1.19 | 460,304 | |
05/20/2025 | 1.40 | 1.41 | 1.30 | 1.37 | 208,012 | |
05/19/2025 | 1.52 | 1.52 | 1.35 | 1.38 | 223,408 | |
05/16/2025 | 1.26 | 1.50 | 1.26 | 1.48 | 470,309 | |
05/15/2025 | 1.47 | 1.48 | 1.14 | 1.21 | 448,353 | |
05/14/2025 | 1.70 | 1.79 | 1.41 | 1.46 | 632,139 | |
05/13/2025 | 1.38 | 1.68 | 1.38 | 1.68 | 704,746 | |
05/12/2025 | 1.35 | 1.42 | 1.30 | 1.36 | 406,025 | |
05/09/2025 | 1.32 | 1.35 | 1.18 | 1.21 | 294,890 | |
05/08/2025 | 1.28 | 1.36 | 1.25 | 1.32 | 320,050 | |
05/07/2025 | 1.17 | 1.30 | 1.15 | 1.27 | 299,323 | |
05/06/2025 | 1.14 | 1.18 | 1.12 | 1.15 | 105,635 | |
05/05/2025 | 1.01 | 1.15 | 1.01 | 1.12 | 178,442 | |
05/02/2025 | 1.03 | 1.07 | 1.03 | 1.05 | 73,812 | |
| 05/01/2025 | 1.03 | 1.06 | 1.01 | 1.03 | 124,744 | |
04/30/2025 | 1.04 | 1.06 | 1.00 | 1.06 | 190,516 | |
04/29/2025 | 1.01 | 1.06 | 0.98 | 1.03 | 135,603 | |
04/28/2025 | 1.00 | 1.06 | 0.92 | 1.00 | 260,666 | |
04/25/2025 | 0.92 | 1.01 | 0.88 | 0.98 | 205,096 | |
04/24/2025 | 0.86 | 0.94 | 0.85 | 0.91 | 120,293 | |
04/23/2025 | 0.82 | 0.88 | 0.81 | 0.88 | 124,894 | |
04/22/2025 | 0.86 | 0.89 | 0.82 | 0.83 | 161,885 |
About ABVC Biopharma Stock history
ABVC Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ABVC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ABVC Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ABVC Biopharma stock prices may prove useful in developing a viable investing in ABVC Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.7 M | 12.3 M | |
| Net Loss | -14.8 M | -14 M |
ABVC Biopharma Stock Technical Analysis
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
ABVC Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ABVC Biopharma's price direction in advance. Along with the technical and fundamental analysis of ABVC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ABVC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2335 | |||
| Jensen Alpha | 2.31 | |||
| Total Risk Alpha | 1.03 | |||
| Sortino Ratio | 0.2402 | |||
| Treynor Ratio | 1.81 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |